Research Report: Coronary Stents Market in India 2013
(M2 PressWIRE Via Acquire Media NewsEdge) Dublin - Research and Markets (http://www.researchandmarkets.com/research/3xfxkk/coronary_stents) has announced the addition of the "Coronary Stents Market in India 2013" report to their offering.
This latest market research report titled Coronary stents Market in India 2013 states that manufacturers of coronary stents are experiencing high demand for their products due to a number of factors. Since cardiovascular diseases have become a common occurrence among the Indian population and the healthcare infrastructure in the country is rapidly improving, it has built a strong case for angioplasty procedures in the country. Moreover, an increase in awareness and the willingness to spend on healthcare is benefiting the market.
Also, advancements in technology such as the introduction of bioabsorbable stents in the Indian market in December 2012 has made such stents more acceptable to patients, thereby providing further stimulus for market growth. With growth in the number of cath labs in the country and their subsequent expansion to smaller cities and towns, angioplasties will become more accessible to patients and will aid in further development of the market.
Products available in the market can be divided into two types - those manufactured by MNCs that command high prices, and those manufactured by domestic companies that are generally priced lower. It is the MNCs that serve the majority of the market with almost all the big hospitals in tier I cities, where most of the angioplasties are performed, preferring to implant stents manufactured by foreign companies over those manufactured by their Indian counterparts.
The general perception is that stents manufactured by MNCs are superior in terms of quality and efficacy, whereas those manufactured by domestic companies fail to attain similar high standards of quality. Also, patients are generally unaware of the choices they have in terms of the types of stents and the various brands that are available in the market, and have to buy stents directly from the hospitals. Since profit margins are higher in case of foreign-manufactured stents, hospitals push for the sale of such stents rather than selling the Indian varieties.
Key Topics Covered:
Drivers & Challenges
- Opto Circuits (India) Ltd.
- Abbott Healthcare Pvt. Ltd.
- B. Braun Medical (India) Pvt. Ltd.
- Boston Scientific India Pvt. Ltd.
- India Medtronic Pvt. Ltd.
- MIV Therapeutics (India) Pvt. Ltd.
- Meril Life Sciences Pvt. Ltd.
- Relisys Medical Devices Ltd.
- Sahajanand Medical Technologies Pvt. Ltd.
- Vascular Concepts Ltd.
For more information visit http://www.researchandmarkets.com/research/3xfxkk/coronary_stents
About Research and Markets
Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Research and Markets,
Fax from USA: 646-607-1907
Fax from rest of the world: +353-1-481-1716
Sector: Medical Devices (http://www.researchandmarkets.com/categories.asp?cat_id=61&campaign_id=3xfxkk)
((M2 Communications disclaims all liability for information provided within M2 PressWIRE. Data supplied by named party/parties. Further information on M2 PressWIRE can be obtained at http://www.presswire.com on the world wide web. Inquiries to email@example.com)).
(c) 2013 M2 COMMUNICATIONS
[ Back To Technology News's Homepage ]